Allostery in disease and in drug discovery

Cell

Volumn 153, Issue 2, 2013, Pages 293-305

  Nussinov, Ruth ^a,b   Tsai, Chung Jung ^a  

^a SAIC FREDERICK INC   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BENZODIAZEPINE DERIVATIVE; CHLOROQUINE; DIAZEPAM; EVEROLIMUS; IMATINIB; MARAVIROC; RAPAMYCIN; TEMSIROLIMUS; TRANSCRIPTION FACTOR NRF2;

ALLOSTERISM; AWARENESS; CANCER CELL; CELL LEVEL; CONFORMATIONAL TRANSITION; DISEASE ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; REVIEW; TREATMENT PLANNING;

EID: 84876266689     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.03.034     Document Type: Review

References (99)

1. F.J. Adrián, Q. Ding, T.B. Sim, A. Velentza, C. Sloan, Y. Liu, G.B. Zhang, W. Hur, S. Ding, and P. Manley Allosteric inhibitors of Bcr-abl-dependent cell proliferation Nat. Chem. Biol. 2 2006 95 102
2. A. Autret, S. Martin-Latil, L. Mousson, A. Wirotius, F. Petit, D. Arnoult, F. Colbere-Garapin, J. Estaquier, and B. Blondel Polovirus induces Bax-dependent cell death mediated by c-Jun NH2-terminal kinase J. Virol. 81 2007 7504 7516
3. M. Azam, M.A. Seeliger, N.S. Gray, J. Kuriyan, and G.Q. Daley Activation of tyrosine kinases by mutation of the gatekeeper threonine Nat. Struct. Mol. Biol. 15 2008 1109 1118
4. D.D. Boehr, R. Nussinov, and P.E. Wright The role of dynamic conformational ensembles in biomolecular recognition Nat. Chem. Biol. 5 2009 789 796
5. J.A. Capra, R.A. Laskowski, J.M. Thornton, M. Singh, and T.A. Funkhouser Predicting protein ligand binding sites by combining evolutionary sequence conservation and 3D structure PLoS. Comput. Biol. 5 2009 e1000585
6. J.P. Changeux Allostery and the Monod-Wyman-Changeux model after 50 years Annu. Rev. Biophys. 41 2012 103 133
7. V. Cherezov, D.M. Rosenbaum, M.A. Hanson, S.G.F. Rasmussen, F.S. Thian, T.S. Kobilka, H.J. Choi, P. Kuhn, W.I. Weis, B.K. Kobilka, and R.C. Stevens High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor Science 318 2007 1258 1265
8. C.N. Chi, A. Bach, Å. Engström, K. Strømgaard, P. Lundström, N. Ferguson, and P. Jemth Biophysical characterization of the complex between human papillomavirus E6 protein and synapse-associated protein 97 J. Biol. Chem. 286 2011 3597 3606
9. P.J. Conn, A. Christopoulos, and C.W. Lindsley Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders Nat. Rev. Drug Discov. 8 2009 41 54
10. P. Csermely, R. Palotai, and R. Nussinov Induced fit, conformational selection and independent dynamic segments: an extended view of binding events Trends Biochem. Sci. 35 2010 539 546
11. Q. Cui, and M. Karplus Allostery and cooperativity revisited Protein Sci. 17 2008 1295 1307
12. A. del Sol, C.J. Tsai, B.Y. Ma, and R. Nussinov The origin of allosteric functional modulation: multiple pre-existing pathways Structure 17 2009 1042 1050
13. X.M. Deng, F.Q. Gao, and W.S. May Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding Blood 113 2009 422 428
14. X.M. Deng, B. Okram, Q.A. Ding, J.M. Zhang, Y.M. Choi, F.J. Adrián, A. Wojciechowski, G.B. Zhang, J.W. Che, and B. Bursulaya Expanding the diversity of allosteric bcr-abl inhibitors J. Med. Chem. 53 2010 6934 6946
15. Y.L. Deribe, T. Pawson, and I. Dikic Post-translational modifications in signal integration Nat. Struct. Mol. Biol. 17 2010 666 672
16. S. Di Marco, C. Volpari, L. Tomei, S. Altamura, S. Harper, F. Narjes, U. Koch, M. Rowley, R. De Francesco, G. Migliaccio, and A. Carfí Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site J. Biol. Chem. 280 2005 29765 29770
17. K.A. Dill, and H.S. Chan From Levinthal to pathways to funnels Nat. Struct. Biol. 4 1997 10 19
18. N.F. Endres, K. Engel, R. Das, E. Kovacs, and J. Kuriyan Regulation of the catalytic activity of the EGF receptor Curr. Opin. Struct. Biol. 21 2011 777 784
19. R.B. Fenwick, S. Esteban-Martín, and X. Salvatella Understanding biomolecular motion, recognition, and allostery by use of conformational ensembles Eur. Biophys. J. 40 2011 1339 1355
20. C. Ferrai, S.Q. Xie, P. Luraghi, D. Munari, F. Ramirez, M.R. Branco, A. Pombo, and M.P. Crippa Poised transcription factories prime silent uPA gene prior to activation PLoS Biol. 8 2010 e1000270
21. H. Frauenfelder, S.G. Sligar, and P.G. Wolynes The energy landscapes and motions of proteins Science 254 1991 1598 1603
22. M. Fuxreiter Fuzziness: linking regulation to protein dynamics Mol. Biosyst. 8 2012 168 177
23. J.J. Gao, and J.A. Wells Identification of specific tethered inhibitors for caspase-5 Chem. Biol. Drug Des. 79 2012 209 215
24. A.C. Gavin, M. Bösche, R. Krause, P. Grandi, M. Marzioch, A. Bauer, J. Schultz, J.M. Rick, A.M. Michon, and C.M. Cruciat Functional organization of the yeast proteome by systematic analysis of protein complexes Nature 415 2002 141 147
25. M. Good, G. Tang, J. Singleton, A. Reményi, and W.A. Lim The Ste5 scaffold directs mating signaling by catalytically unlocking the Fus3 MAP kinase for activation Cell 136 2009 1085 1097
26. M.C. Good, J.G. Zalatan, and W.A. Lim Scaffold proteins: hubs for controlling the flow of cellular information Science 332 2011 680 686
27. N.M. Goodey, and S.J. Benkovic Allosteric regulation and catalysis emerge via a common route Nat. Chem. Biol. 4 2008 474 482
28. B.D. Grant, and J.A. Adams Pre-steady-state kinetic analysis of cAMP-dependent protein kinase using rapid quench flow techniques Biochemistry 35 1996 2022 2029
29. K. Gunasekaran, B.Y. Ma, and R. Nussinov Is allostery an intrinsic property of all dynamic proteins? Proteins 57 2004 433 443
30. M. Gupta, A.E.W. Hendrickson, S.S. Yun, J.J. Han, P.A. Schneider, B.D. Koh, M.J. Stenson, L.E. Wellik, J.C. Shing, and K.L. Peterson Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies Blood 119 2012 476 487
31. A.Q. Hassan, S.V. Sharma, and M. Warmuth Allosteric inhibition of BCR-ABL Cell Cycle 9 2010 3710 3714
32. V.J. Hilser, J.O. Wrabl, and H.N. Motlagh Structural and energetic basis of allostery Annu. Rev. Biophys. 41 2012 585 609
33. M. Huse, and J. Kuriyan The conformational plasticity of protein kinases Cell 109 2002 275 282
34. C.M. Johannessen, J.S. Boehm, S.Y. Kim, S.R. Thomas, L. Wardwell, L.A. Johnson, C.M. Emery, N. Stransky, A.P. Cogdill, and J. Barretina COT drives resistance to RAF inhibition through MAP kinase pathway reactivation Nature 468 2010 968 972
35. R.E. Joseph, Q.A. Xie, and A.H. Andreotti Identification of an allosteric signaling network within Tec family kinases J. Mol. Biol. 403 2010 231 242
36. N. Jura, X.W. Zhang, N.F. Endres, M.A. Seeliger, T. Schindler, and J. Kuriyan Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms Mol. Cell 42 2011 9 22
37. G. Kar, O. Keskin, A. Gursoy, and R. Nussinov Allostery and population shift in drug discovery Curr. Opin. Pharmacol. 10 2010 715 722
38. T.P. Kenakin '7TM receptor allostery: putting numbers to shapeshifting proteins Trends Pharmacol. Sci. 30 2009 460 469
39. T. Kenakin, and L.J. Miller Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery Pharmacol. Rev. 62 2010 265 304
40. C. Kim, D. Vigil, G. Anand, and S.S. Taylor Structure and dynamics of PKA signaling proteins Eur. J. Cell Biol. 85 2006 651 654
41. Z.A. Knight, and K.M. Shokat Features of selective kinase inhibitors Chem. Biol. 12 2005 621 637
42. S. Kumar, B. Ma, C.J. Tsai, N. Sinha, and R. Nussinov Folding and binding cascades: dynamic landscapes and population shifts Protein Sci. 9 2000 10 19
43. J. Kuriyan, and D. Eisenberg The origin of protein interactions and allostery in colocalization Nature 450 2007 983 990
44. A. Lau, N.F. Villeneuve, Z. Sun, P.K. Wong, and D.D. Zhang Dual roles of Nrf2 in cancer Pharmacol. Res. 58 2008 262 270
45. B.C. Lechtenberg, S.M. Freund, and J.A. Huntington An ensemble view of thrombin allostery Biol. Chem. 393 2012 889 898
46. J. Lee, M. Natarajan, V.C. Nashine, M. Socolich, T. Vo, W.P. Russ, S.J. Benkovic, and R. Ranganathan Surface sites for engineering allosteric control in proteins Science 322 2008 438 442
47. D.M. Leitner Energy flow in proteins Annu. Rev. Phys. Chem. 59 2008 233 259
48. S.B. Liggett Phosphorylation barcoding as a mechanism of directing GPCR signaling Sci. Signal. 4 2011 pe36
49. Z. Liu, J. Chen, and D. Thirumalai On the accuracy of inferring energetic coupling between distant sites in protein families from evolutionary imprints: illustrations using lattice model Proteins 77 2009 823 831
50. B.Y. Ma, S. Kumar, C.J. Tsai, and R. Nussinov Folding funnels and binding mechanisms Protein Eng. 12 1999 713 720
51. B. Ma, C.-J. Tsai, T. Haliloǧlu, and R. Nussinov Dynamic allostery: linkers are not merely flexible Structure 19 2011 907 917
52. G. Maksay Allostery in pharmacology: thermodynamics, evolution and design Prog. Biophys. Mol. Biol. 106 2011 463 473
53. M.A. Martí, D.A. Estrin, and A.E. Roitberg Molecular basis for the pH dependent structural transition of Nitrophorin 4 J. Phys. Chem. B 113 2009 2135 2142
54. A. Martín-Montalvo, J.M. Villalba, P. Navas, and R. de Cabo NRF2, cancer and calorie restriction Oncogene 30 2011 505 520
55. L.R. Masterson, A. Mascioni, N.J. Traaseth, S.S. Taylor, and G. Veglia Allosteric cooperativity in protein kinase A Proc. Natl. Acad. Sci. USA 105 2008 506 511
56. M. Mazzoletti, F. Bortolin, L. Brunelli, R. Pastorelli, S. Di Giandomenico, E. Erba, P. Ubezio, and M. Broggini Combination of PI3K/mTOR inhibitors: antitumor activity and molecular correlates Cancer Res. 71 2011 4573 4584
57. S. Medves, and J.B. Demoulin Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies J. Cell. Mol. Med. 16 2012 237 248
58. J.A. Mitchell, and P. Fraser Transcription factories are nuclear subcompartments that remain in the absence of transcription Genes Dev. 22 2008 20 25
59. J. Monod, J. Wyman, and J.P. Changeux On the nature of allosteric transitions: a plausible model J. Mol. Biol. 12 1965 88 118
60. S. Nachtergaele, L.K. Mydock, K. Krishnan, J. Rammohan, P.H. Schlesinger, D.F. Covey, and R. Rohatgi Oxysterols are allosteric activators of the oncoprotein Smoothened Nat. Chem. Biol. 8 2012 211 220
61. B. Nolen, S. Taylor, and G. Ghosh Regulation of protein kinases; controlling activity through activation segment conformation Mol. Cell 15 2004 661 675
62. R. Nussinov Allosteric modulators can restore function in an amino acid neurotransmitter receptor by slightly altering intra-molecular communication pathways Br. J. Pharmacol. 165 2012 2110 2112
63. R. Nussinov, C.-J. Tsai, and P. Csermely Allo-network drugs: harnessing allostery in cellular networks Trends Pharmacol. Sci. 32 2011 686 693
64. R. Nussinov, C.J. Tsai, F. Xin, and P. Radivojac Allosteric post-translational modification codes Trends Biochem. Sci. 37 2012 447 455
65. R. Nussinov, C.-J. Tsai, and B. Ma The (still) underappreciated role of allostery in the cellular network Annu. Rev. Biophysics 2013 10.1146/annurev-biophys-083012-130257 Published online February 28, 2013
66. C.S. Osborne, L. Chakalova, K.E. Brown, D. Carter, A. Horton, E. Debrand, B. Goyenechea, J.A. Mitchell, S. Lopes, W. Reik, and P. Fraser Active genes dynamically colocalize to shared sites of ongoing transcription Nat. Genet. 36 2004 1065 1071
67. Y.P. Pan, C.J. Tsai, B.Y. Ma, and R. Nussinov Mechanisms of transcription factor selectivity Trends Genet. 26 2010 75 83
68. R.B. Paulsen, P.P. Seth, E.E. Swayze, R.H. Griffey, J.J. Skalicky, T.E. Cheatham 3rd, and D.R. Davis Inhibitor-induced structural change in the HCV IRES domain IIa RNA Proc. Natl. Acad. Sci. USA 107 2010 7263 7268
69. T. Pawson Dynamic control of signaling by modular adaptor proteins Curr. Opin. Cell Biol. 19 2007 112 116
70. S.J. Pfaff, and R.J. Fletterick Hormone binding and co-regulator binding to the glucocorticoid receptor are allosterically coupled J. Biol. Chem. 285 2010 15256 15267
71. N. Popovych, S.J. Sun, R.H. Ebright, and C.G. Kalodimos Dynamically driven protein allostery Nat. Struct. Mol. Biol. 13 2006 831 838
72. K.A. Reynolds, R.N. McLaughlin, and R. Ranganathan Hot spots for allosteric regulation on protein surfaces Cell 147 2011 1564 1575
73. A.M. Ruschak, M. Slassi, L.E. Kay, and A.D. Schimmer Novel proteasome inhibitors to overcome bortezomib resistance J. Natl. Cancer Inst. 103 2011 1007 1017
74. J.D. Sadowsky, M.A. Burlingame, D.W. Wolan, C.L. McClendon, M.P. Jacobson, and J.A. Wells Turning a protein kinase on or off from a single allosteric site via disulfide trapping Proc. Natl. Acad. Sci. USA 108 2011 6056 6061
75. D. Schelshorn, F. Joly, S. Mutel, C. Hampe, B. Breton, V. Mutel, and R. Lütjens Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation Mol. Pharmacol. 81 2012 309 318
76. E. Segal, and J. Widom What controls nucleosome positions? Trends Genet. 25 2009 335 343
77. Q. Shan, L. Han, and J.W. Lynch Function of hyperekplexia-causing α1R271Q/L glycine receptors is restored by shifting the affected residue out of the allosteric signalling pathway Br. J. Pharmacol. 165 2012 2113 2123
78. Y. Shan, M.P. Eastwood, X. Zhang, E.T. Kim, A. Arkhipov, R.O. Dror, J. Jumper, J. Kuriyan, and D.E. Shaw Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization Cell 149 2012 860 870
79. L.S. Shopland, C.V. Johnson, M. Byron, J. McNeil, and J.B. Lawrence Clustering of multiple specific genes and gene-rich R-bands around SC-35 domains: evidence for local euchromatic neighborhoods J. Cell Biol. 162 2003 981 990
80. J. Singh, R.C. Petter, T.A. Baillie, and A. Whitty The resurgence of covalent drugs Nat. Rev. Drug Discov. 10 2011 307 317
81. N. Sinha, and R. Nussinov Point mutations and sequence variability in proteins: redistributions of preexisting populations Proc. Natl. Acad. Sci. USA 98 2001 3139 3144
82. N.J. Smith, and G. Milligan Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes Pharmacol. Rev. 62 2010 701 725
83. D. Strickland, K. Moffat, and T.R. Sosnick Light-activated DNA binding in a designed allosteric protein Proc. Natl. Acad. Sci. USA 105 2008 10709 10714
84. H. Sutherland, and W.A. Bickmore Transcription factories: gene expression in unions? Nat. Rev. Genet. 10 2009 457 466
85. S.S. Taylor, and A.P. Kornev Protein kinases: evolution of dynamic regulatory proteins Trends Biochem. Sci. 36 2011 65 77
86. S.S. Taylor, C. Kim, D. Vigil, N.M. Haste, J. Yang, J. Wu, and G.S. Anand Dynamics of signaling by PKA Biochim. Biophys. Acta 1754 2005 25 37
87. C.J. Tsai, S. Kumar, B.Y. Ma, and R. Nussinov Folding funnels, binding funnels, and protein function Protein Sci. 8 1999 1181 1190
88. C.J. Tsai, B.Y. Ma, and R. Nussinov Folding and binding cascades: shifts in energy landscapes Proc. Natl. Acad. Sci. USA 96 1999 9970 9972
89. C.J. Tsai, A. del Sol, and R. Nussinov Allostery: absence of a change in shape does not imply that allostery is not at play J. Mol. Biol. 378 2008 1 11
90. C.J. Tsai, A. Del Sol, and R. Nussinov Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms Mol. Biosyst. 5 2009 207 216
91. S.R. Tzeng, and C.G. Kalodimos Protein dynamics and allostery: an NMR view Curr. Opin. Struct. Biol. 21 2011 62 67
92. P. Weinkam, J. Pons, and A. Sali Structure-based model of allostery predicts coupling between distant sites Proc. Natl. Acad. Sci. USA 109 2012 4875 4880
93. M.J. Whitley, and A.L. Lee Frameworks for understanding long-range intra-protein communication Curr. Protein Pept. Sci. 10 2009 116 127
94. M.R. Wood, C.R. Hopkins, J.T. Brogan, P.J. Conn, and C.W. Lindsley "Molecular switches" on mGluR allosteric ligands that modulate modes of pharmacology Biochemistry 50 2011 2403 2410
95. J.O. Wrabl, J. Gu, T. Liu, T.P. Schrank, S.T. Whitten, and V.J. Hilser The role of protein conformational fluctuations in allostery, function, and evolution Biophys. Chem. 159 2011 129 141
96. C.-H. Yun, T.J. Boggon, Y. Li, M.S. Woo, H. Greulich, M. Meyerson, and M.J. Eck Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity Cancer Cell 11 2007 217 227
97. J.M. Zhang, F.J. Adrián, W. Jahnke, S.W. Cowan-Jacob, A.G. Li, R.E. Iacob, T. Sim, J. Powers, C. Dierks, and F.X. Sun Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors Nature 463 2010 501 506
98. P.I. Zhuravlev, and G.A. Papoian Protein functional landscapes, dynamics, allostery: a tortuous path towards a universal theoretical framework Q. Rev. Biophys. 43 2010 295 332
99. G. Zocchi Controlling proteins through molecular springs Annu. Rev. of Biophys. 38 2009 75 88